Detalhe da pesquisa
1.
Deconstructing magnetization noise: Degeneracies, phases, and mobile fractionalized excitations in tetris artificial spin ice.
Proc Natl Acad Sci U S A
; 120(43): e2310777120, 2023 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851675
2.
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
Blood
; 141(19): 2359-2371, 2023 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626250
3.
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
Hematol Oncol
; 41(4): 743-752, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086447
4.
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
Cancer
; 128(21): 3880-3887, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107670
5.
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Blood
; 135(7): 463-471, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841594
6.
Evaluation of a Community-Based Harm Reduction Intervention Aimed at Adjudicated College Students.
J Drug Educ
; 50(1-2): 45-62, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34714710
7.
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.
Proc Natl Acad Sci U S A
; 114(36): E7554-E7563, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784769
8.
Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.
J Transl Med
; 17(1): 163, 2019 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31109340
9.
Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.
J Transl Med
; 17(1): 301, 2019 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484534
10.
Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia.
Mod Pathol
; 31(3): 429-441, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29192651
11.
A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy.
Int J Mol Sci
; 18(7)2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28696354
12.
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?
Am J Hematol
; 91(3): 277-82, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26663264
13.
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center.
Br J Haematol
; 171(1): 84-90, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26115047
14.
Self-assembled ErSb nanostructures with optical applications in infrared and terahertz.
Nano Lett
; 14(3): 1107-12, 2014 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24206535
15.
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML).
Leuk Lymphoma
; : 1-8, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538632
16.
Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome.
Blood Adv
; 2024 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640348
17.
The future paradigm of HMA + VEN or targeted inhibitor approaches: sequencing or triplet combinations in AML therapy.
Hematology Am Soc Hematol Educ Program
; 2023(1): 192-197, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066868
18.
Olutasidenib: from bench to bedside.
Blood Adv
; 7(16): 4358-4365, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196640
19.
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.
Blood Adv
; 7(13): 3117-3127, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724515
20.
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial.
Lancet Haematol
; 10(1): e46-e58, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370742